Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TachoSil for Lymphocele Prevention in Pelvic Lymphadenectomy
NCT03752606Phase 4Completed
- Sponsor
- Medical University of Lublin
- Start
- Nov 2013
- Primary completion
- Dec 2014
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of tachosil in lymphocele (2 arms), sponsored by Medical University of Lublin. Primary endpoints: The incidence of lymphocele at 1 year and The volume of lymphocele at 1 year. Started Nov 2013; status: completed.
02
Drugs
tachosil
03
Conditions
lymphocele
Beyond the preview
Go deeper on NCT03752606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03752606.